Article
Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India
1 Oct 2013
Abstract excerpt
Sir, Triazole antifungals are the mainstay of therapy for patients with aspergillosis. Notably, the mortality associated with aspergillosis is high and the rate of treatment failure is much higher if patients are infected with multiple-triazole-resistant (MTR) Aspergillus fumigatus.1,2 MTR A. fumigatus strains with the mutation TR34/L98H occur both in azole-treated as well as in azole-naive patients and have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
